The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma
Open Access
- 7 March 2006
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 94 (5) , 647-653
Abstract
The influence of perioperative blood transfusion in oral and oropharyngeal squamous cell carcinoma remains uncertain. It is believed that blood transfusion downregulates the immune system and may have an influence on cancer recurrence and survival. In all, 559 consecutive patients undergoing primary surgery for oral and oropharyngeal squamous cell carcinoma between 1992 and 2002 were included in this study. Known prognostic variables along with transfusion details were obtained from head and neck cancer and blood transfusion service databases, respectively. Adjusting for relevant prognostic factors in Cox regression, the hazard ratio for patients having 3 or more transfused units relative to those not transfused was 1.52 (95% confidence interval (CI) 0.93–2.47) for disease-specific and 1.52 (95% CI 1.05–2.22) for overall mortality. Blood transfusion of 3 or more units might confer a worse prognosis in patients undergoing primary surgery for oral and oropharyngeal squamous cell carcinoma. Therefore, every effort should be made to limit the amount of blood transfused to the minimum requirement.Keywords
This publication has 26 references indexed in Scilit:
- Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgeryInternational Journal of Oral and Maxillofacial Surgery, 2004
- Influence of Anaemia in Patients with Head and Neck Cancer Receiving Adjuvant Postoperative Radiotherapy in the Grampian RegionClinical Oncology, 2004
- The Effects of Epoetin Alfa on Transfusion Requirements in Head and Neck Cancer Patients: A Prospective, Randomized, Placebo‐Controlled StudyThe Laryngoscope, 2002
- Death certification in patients whose primary treatment for oral andoropharyngeal carcinoma was operation: 1992–1997British Journal of Oral and Maxillofacial Surgery, 2001
- The Association Between Preoperative Concentration of Soluble Vascular Endothelial Growth Factor, Perioperative Blood Transfusion, and Survival in Patients with Primary Colorectal CancerBritish Journal of Surgery, 2001
- Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?Blood, 2001
- Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neckThe Laryngoscope, 1994
- Blood transfusion and laryngeal cancerClinical Otolaryngology, 1991
- RED BLOOD CELLS FOR CANCER PATIENTSThe Lancet, 1981
- Improvement of Kidney-Graft Survival with Increased Numbers of Blood TransfusionsNew England Journal of Medicine, 1978